New TB Drug Regimen Controls Resistant Disease in 9 of 10 Cases - Study New TB Drug Regimen Controls Resistant Disease in 9 of 10 Cases - Study

The new anti-tuberculosis drug combination of bedaquiline, pretomanid and linezolid cures 90% of people with deadly drug-resistant TB if given for six months, according to results published in the New England Journal of Medicine.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Pulmonary Medicine News Source Type: news